Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s12029-018-0116-1
Published Online: 2018-05-25
Published Print: 2019-09-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rayan, Amal http://orcid.org/0000-0001-5995-9177
Abdel Fattah, Ola N.
Soliman, Ahmed
Hasan, Hosam A.
Zahran, Asmaa M.
Text and Data Mining valid from 2018-05-25
Version of Record valid from 2018-05-25
Article History
First Online: 25 May 2018